JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 102 filers reported holding JUNO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $6,000 | -14.3% | 125 | -50.0% | 0.01% | 0.0% |
| Q2 2017 | $7,000 | -75.0% | 250 | -83.3% | 0.01% | -76.1% |
| Q4 2016 | $28,000 | -42.9% | 1,500 | -7.7% | 0.05% | -46.5% |
| Q3 2016 | $49,000 | -26.9% | 1,625 | -7.1% | 0.09% | -19.6% |
| Q2 2016 | $67,000 | +570.0% | 1,750 | +600.0% | 0.11% | +613.3% |
| Q1 2016 | $10,000 | -37.5% | 250 | -33.3% | 0.02% | -34.8% |
| Q4 2015 | $16,000 | +60.0% | 375 | +50.0% | 0.02% | +64.3% |
| Q3 2015 | $10,000 | -69.7% | 250 | -60.0% | 0.01% | -63.2% |
| Q2 2015 | $33,000 | +450.0% | 625 | +525.0% | 0.04% | +442.9% |
| Q1 2015 | $6,000 | -84.6% | 100 | -86.7% | 0.01% | -84.4% |
| Q4 2014 | $39,000 | – | 750 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |